» Articles » PMID: 29576781

The New Mayo Clinic Risk Score Characteristics in Acute Coronary Syndrome in Patients Following Percutaneous Coronary Intervention

Overview
Date 2018 Mar 27
PMID 29576781
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Mortality and major adverse cardiac events (MACE) frequently occur after percutaneous coronary intervention (PCI). Therefore, the ability to predict such events through an established risk stratification method is of great importance. The present study was aimed at determining the risk stratification of mortality and MACE in post-PCI patients at the intensive cardiac care unit of Cipto Mangunkusumo Hospital (CMH) using 7 variables of the New Mayo Clinic Risk Score (NMCRS). This cross-sectional study drew upon secondary data gathered from the medical records of 313 patients that underwent PCI at the intensive cardiac care unit (ICCU) of CMH between August 1st, 2013, and August 31st, 2014. The primary end point was all-cause mortality and MACE. Seven variables in the NMCRS, namely age, left ventricular ejection fraction, serum creatinine, preprocedural cardiogenic shock, myocardial infarction, and peripheral arterial disease, were evaluated. The mortality and MACE incidence rates in the post-PCI patients were 3.8% (95%CI: 2.6-5.0) and 8.3% (95% CI: 6.6-10.0), respectively. Regarding the NMCRS stratification, elderly patients with lower left ventricular ejection fraction, increased serum creatinine, preprocedural cardiogenic shock, myocardial infarction, and peripheral arterial disease had higher mortality and MACE incidence rates among the post-PCI patients. The mortality and MACE incidence rates significantly increased in the post-PCI patients with a higher NMCRS. Patients with a higher NMCRS had a tendency toward higher mortality and MACE incidence rates following PCI.

Citing Articles

Accuracy of machine learning in predicting outcomes post-percutaneous coronary intervention: a systematic review.

Wee C, Tan C, Yau C, Teo Y, Go R, Teo Y AsiaIntervention. 2024; 10(3):219-232.

PMID: 39347111 PMC: 11413637. DOI: 10.4244/AIJ-D-23-00023.


The association between 24-h blood pressure variability and major adverse cardiac events (MACE) in hospitalized patients with acute myocardial infarction: a retrospective cohort study.

Harefa , Wijaya I, Muhadi , Rumende C, Nasution S, Koesnoe S Egypt Heart J. 2021; 73(1):88.

PMID: 34648099 PMC: 8517047. DOI: 10.1186/s43044-021-00213-1.


Modified CHADS-VASc score predicts in-hospital mortality and procedural complications in acute coronary syndrome treated with percutaneous coronary intervention.

Abugroun A, Hassan A, Gaznabi S, Ayinde H, Subahi A, Samee M Int J Cardiol Heart Vasc. 2020; 28:100532.

PMID: 32455161 PMC: 7235953. DOI: 10.1016/j.ijcha.2020.100532.

References
1.
Hochman J, Boland J, Sleeper L, Porway M, Brinker J, Col J . Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators. Circulation. 1995; 91(3):873-81. DOI: 10.1161/01.cir.91.3.873. View

2.
Singh M, Peterson E, Roe M, Ou F, Spertus J, Rumsfeld J . Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience. Circ Cardiovasc Interv. 2009; 2(1):20-6. DOI: 10.1161/CIRCINTERVENTIONS.108.826172. View

3.
Kelly D, Gershlick T, Witzenbichler B, Guagliumi G, Fahy M, Dangas G . Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Am Heart J. 2011; 162(4):663-70. DOI: 10.1016/j.ahj.2011.08.002. View

4.
Chin S, Jeyaindran S, Azhari R, Wan Azman W, Omar I, Robaayah Z . Acute coronary syndrome (ACS) registry--leading the charge for National Cardiovascular Disease (NCVD) Database. Med J Malaysia. 2009; 63 Suppl C:29-36. View

5.
Passos L, Lopes A, Costa U, Lobo N, Rabelo Junior A . Difference in the in-hospital mortality of unstable angina pectoris between men and women. Arq Bras Cardiol. 2001; 72(6):669-76. DOI: 10.1590/s0066-782x1999000600002. View